Cervavac was developed by Serum Institute Of India (SII) in collaboration with central government’s department of ...

Updated phase 3 data support pembrolizumab plus concurrent chemoradiotherapy as a standard of care for patients with high-risk, locally advanced cervical cancer, according to Linda Duska, MD.

Schistosoma haematobium can trigger cancer-related gene activity in the cervix, increasing the risk for cervical cancer, according to data presented at the ESCMID Global meeting.

Denmark aims to eradicate cervical cancer by 2040 thanks to a national HPV vaccination campaign and screening program, the ...

Cervical cancer in women has long been the cancer primarily associated with HPV, and that shows in the survey results from OSUCCC. Nearly half of the respondents believe that HPV is more common in ...

The research is published in the journal Scientific Reports. The team discovered a novel global cooperative phenomenon, a hidden causal interaction network, in monolayers of HeLa cervical cancer ...

The trial included 316 patients with stage I-IIA cervical cancer with at least 2 intermediate ... particularly neutropenia (17 % vs 1%) and leukopenia (28% vs 2%). Premal Thaker, MD, discussant ...

She had Stage 1 cancer, and doctors performed another cervical cone biopsy in the hope of removing it all. But the tests revealed the cancer had spread farther than they realized. “They did not ...

0.49-1.07). Eligible patients had high-risk locally advanced cervical cancer, defined as FIGO stage IB2-IIB or FIGO 2014 stage III-IVA disease, regardless of the node status. Patients were ...